The results of almost 1,600 individuals with a first episode of psychosis who had undergone an MRI brain scan were analyzed by researchers led by Dr Graham Blackman and Professor Philip McGuire at the University of Oxford.
They discovered that approximately 6% of patients had a scan abnormality, which resulted in a new diagnosis or a change in their therapeutic management.
Dr Blackman, an NIHR (National Institute for Health and Care Research) Clinical Lecturer at the University, says:“Patients presenting with psychosis may have another physical illness or condition causing their symptoms that can be identified using MRI scanning. A failure to detect these causes at an early stage can have serious consequences, such as a delay in providing the appropriate treatment.”
“Our findings suggest that MRI scans should be considered as part of the initial assessment of all people with first-episode psychosis to ensure that they get the right diagnosis and the right treatment.”
Although performing a brain scan on new patients with psychosis is considered best practice, it is not required. Previously, a NICE Technology Appraisal was unable to suggest scanning in all patients since it was unclear at the time how common clinically important brain abnormalities are in persons with first-episode psychosis.
Prof McGuire added: “We feel that this study addresses a critical knowledge gap in this area by showing that clinically relevant abnormalities occur frequently enough to justify making MRI scanning a routine part of the assessment of people presenting with psychosis for the first time. This new evidence has important implications for clinical care in psychosis and a review of the NICE guidance in this area would be helpful.”
more recommended stories
-
Multiple Surgeries Linked to Cognitive Decline in Older Adults
A University of Sydney study has.
-
MMR Vaccine Effectiveness Declines Over Time
A modelling study conducted in England.
-
Telehealth Expands Access to Pediatric Physiatry Care
In California’s rural towns, telehealth is.
-
Single-Dose Gene Therapy: A Breakthrough for Hemophilia B Treatment
The outcomes of an international Phase.
-
AI Identifies Drugs for Rare Diseases Treatment
A groundbreaking AI model called TxGNN.
-
Inflammatory Immune Cells Linked to Prostate Cancer Resistance
Prostate and many other cancers have.
-
Microbial Biomarkers in Lupus & IBD: Pathways to Targeted Therapies
Researchers found the microbial profiles associated.
-
Genetic Factors Linked to Severe Cholera Symptoms Discovered
The genetic components that make the.
-
Blood MicroRNAs: Predicting Alzheimer’s Progression
Researchers discovered the serum micro-ribonucleic acid.
-
Anti-fibrotic Drug Shows Promise in Breast Cancer Treatment
The most prevalent type of breast.
Leave a Comment